Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,280 | 1,840 | 4,410 | 3,020 | 2,290 |
| TOTAL | $2,280 | $1,840 | $4,410 | $3,020 | $2,290 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 63,950 | 65,490 | 64,790 | 57,920 | 59,120 |
| TOTAL | $63,950 | $65,490 | $64,790 | $57,920 | $59,120 |
| Total Assets | $66,230 | $67,330 | $69,200 | $60,940 | $61,410 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,080 | 4,860 | 4,600 | 4,280 | 3,850 |
| Accounts payable and accrued liabilities | 19,380 | 15,600 | 17,430 | 15,960 | 12,960 |
| Other current liabilities | 9,780 | 5,230 | 8,840 | 5,700 | 5,530 |
| TOTAL | $39,440 | $26,350 | $34,220 | $25,940 | $22,340 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7,710 | 22,330 | 28,470 | 23,760 | 24,120 |
| TOTAL | $30,200 | $22,330 | $28,470 | $23,760 | $24,120 |
| Total Liabilities | $69,640 | $48,680 | $62,690 | $49,700 | $46,460 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 70 | 70 |
| Other shareholders' equity | 3,250 | 2,460 | 1,430 | -7,830 | -8,150 |
| TOTAL | $443,470 | $442,110 | $440,870 | $430,990 | $429,080 |
| Total Liabilities And Equity | $513,110 | $490,790 | $503,560 | $480,690 | $475,540 |